AnodyneWiki

Methadone

Methadone
Methadone
Salts
[]
Methadone hydrobromide
Methadone hydrobromide
Methadone hydrochloride
Methadone hydrochloride
Methadone tartrate
Methadone tartrate
Methadone hydriodide
Methadone hydriodide
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass309.40 g/mol [1]
Melting point235 °C [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
SolubilityPlatelets from alcohol + ether; mp, 235 °C; bitter taste; UV maximum, 292 nm; solubility (g/100 mL) water, 12; alcohol, 8; isopropanol, 2.4; Practically insoluble in ether, glycerol; pH of a 1% aqueous solution is 4.5-5.6 /Methadone hydrochloride/ [1]
Predicted LogP3.9 [1]
Structural Identifiers
[]
Molecular formulaC21H27NO
IUPAC name6-(dimethylamino)-4,4-diphenylheptan-3-one
SMILESCCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChIInChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3
InChIKeyUSSIQXCVUWKGNF-UHFFFAOYSA-N
CAS number76-99-3
UNIIUC6VBE7V1Z
PubChem CID4095
Pharmacokinetics[]
OnsetRapid
Elimination half-life15–55 hours
Duration of actionSingle dose: 4–8 h, Prolonged use:, • Withdrawal prevention: 1–2 days, • Pain relief: 8–12 hours
MetabolismLiver (CYP3A4, CYP2B6 and CYP2D6-mediated)[3]
ExcretionUrine, faeces
Routes of administrationBy mouth, intravenous, insufflation, sublingual, rectal
Addiction liabilityHigh[4]
Toxicity
[]
Rat:
- oral: 86 mg/kg
- ip: 18 mg/kg
- sc: 30 mg/kg
- iv: 11 mg/kg
 [1]
Dosing[]
Oral
[]
Threshold0.5 - 1
Light1 - 5
Common5 - 10
Strong10 - 20
Heavy20 - 29.10000000000001
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki)
We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly.

Methadone (also known as dl-Methadone, Diaminon, Phenadone, Dolophin, Heptadone, Ketalgin, Methadon, Adanon, Amidone or Algovetin) is a depressant, hormone and opioid substance of the phenylpropylamine class.

Chemistry

Salts []

Methadone is typically found in the form of its hydrobromide, hydrochloride, tartrate and hydriodide salts.

 []

Methadone is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

Methadone matches Lipinski's rule of five.

There are currently 7 reagent-interactions on

ReagentColor changeDescription
Marquisyellowish pink > violet
Meckeno color change
Mandelingreen / green > blue
Liebermannyellowish / brownish
Froehdeblue
Simon'sno blue color change
Scottno color change

Pharmacology

Mechanism of action []

Methadone is a synthetic opioid analgesic with full agonist activity at the µ-opioid receptor. While agonism of the µ-opioid receptor is the primary mechanism of action for the treatment of pain, methadone also acts as an agonist of κ- and σ-opioid receptors within the central and peripheral nervous systems. Interestingly, methadone differs from [morphine] (which is considered the gold standard reference opioid) in its antagonism of the N-methyl-D-aspartate (NMDA) receptor and its strong inhibition of serotonin and norepinephrine uptake, which likely also contributes to its antinociceptive activity. Methadone is administered as a 50:50 racemic mixture of (R)- and (S)-stereoisomers, with (R)-methadone demonstrating ~10-fold higher affinity and potency for the µ-opioid receptor than the (S) stereoisomer. The analgesic activity of the racemate is almost entirely due to the (R)-isomer, while the (S)-isomer lacks significant respiratory depressant activity but does have antitussive effects. While methadone shares similar effects and risks of other opioids such as [morphine], [hydromorphone], [oxycodone], and [fentanyl] it has a number of unique pharmacokinetic and pharmacodynamic properties that distinguish it from them and make it a useful agent for the treatment of opioid addiction. For example, methadone abstinence syndrome, although qualitatively similar to that of morphine, differs in that the onset is slower, the course is more prolonged, and the symptoms are less severe. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / induction / inhibition285 (6 contraindicated)
inhibition / induction / metabolism37 (1 contraindicated)
metabolism / inhibition / induction34 (1 contraindicated)
transporter inhibition / transporter induction33
metabolism / inhibition / induction33
metabolism / induction / inhibition30
shared target12 (1 contraindicated)
shared target4
shared target4
shared target4
shared target4
shared target4

Medical side effects []

108 side effects listed on drug labels in (methadone).

  • Abdominal pain
  • Gastrointestinal pain
  • Bowel spasm
  • Amenorrhoea
  • Anaphylactic shock
  • Decreased appetite
  • Anxiety
  • Arrhythmia
  • Asthenia
  • Confusional state
  • Feeling abnormal
  • Constipation
  • Libido decreased
  • Disturbance in sexual arousal
  • Dermatitis contact
  • Diarrhoea
  • Dizziness
  • Syncope
  • Lightheadedness
  • Somnolence
  • Oedema
  • Dermatitis
  • Rash
  • Body temperature increased
  • Flushing
  • Multiple fractures
  • Fracture
  • Glossitis
  • Hallucination
  • Head injury
  • Headache
  • Cardiac arrest
  • Cardiac failure
  • Chronic hepatitis
  • Hypersensitivity
  • Hypogonadism
  • Hypokalaemia
  • Hypotension
  • Hypotensive
  • Orthostatic hypotension
  • Body temperature decreased
  • Hypothermia
  • Irritability
  • Lung disorder
  • Miosis
  • Mydriasis
  • Nausea
  • Osteoporosis
  • Palpitations
  • Phlebitis
  • Piloerection
  • Cutis anserina
  • Pruritus
  • Pulmonary oedema
  • Convulsion
  • Shock
  • Sneezing
  • Muscle spasms
  • Withdrawal syndrome
  • Hyperhidrosis
  • Sweating increased
  • Swelling
  • Loss of consciousness
  • Tachycardia
  • Thrombocytopenia
  • Torsade de pointes
  • Tremor
  • Erythema
  • Redness
  • Urticaria
  • Ventricular fibrillation
  • Ventricular tachycardia
  • Vertigo
  • Vomiting
  • Weight increased
  • Weight decreased
  • Dry mouth
  • Yawning
  • Urinary retention
  • Chills
  • Agitation
  • Drug withdrawal syndrome
  • Hypomagnesaemia
  • Intracranial pressure increased
  • Electrocardiogram QT prolonged
  • Respiratory arrest
  • Muscle twitching
  • Disorientation
  • Dysphoria
  • Pain
  • Respiratory depression
  • Pulmonary function test decreased
  • Euphoric mood
  • Muscle mass
  • Extrasystoles
  • Lacrimation increased
  • Bradycardia
  • Electrocardiogram T wave inversion
  • Visual impairment
  • Drug interaction
  • Feeling cold
  • Blood testosterone decreased
  • Cardiomyopathy
  • Insomnia
  • Haemorrhagic urticaria
  • Nasopharyngitis
  • Rhinorrhoea
  • Cardiovascular insufficiency

Indications

  • Acute pain
  • Analgesic effect
  • Convulsion
  • Dependence on opiates
  • Heroin addiction
  • Opioid naive
  • Pain
  • Postoperative pain
  • Respiratory depression
  • Substance abuse
  • Withdrawal syndrome

Subjective effects []

Experience reports

Erowid

There are currently 30 experience reports involving methadone on : []

 []

  • Australia: Methadone is a Schedule 8.
  • Brazil: Methadone is a A1.
  • Canada: Methadone is a Schedule I.
  • Germany: Methadone is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
  • New Zealand: Methadone is a Class B3.[5]
  • United Kingdom: Methadone is a Class A under the "Misuse of Drugs Act 1971".
  • United States: Methadone is a Schedule II under the "Controlled Substances Act".
  • European Union: Methadone is Prescription only.
  • Other: Methadone is a SE: Förteckning II.[6]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 4095, Methadone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4095
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methadone. UNII: UC6VBE7V1Z. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/UC6VBE7V1Z
  3. Brown R, Kraus C, Fleming M, Reddy S. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgraduate Medical Journal. November 2004; 80(949):654–659. PMID 15537850. http://pmj.bmj.com/content/80/949/654.full.pdf
  4. Bonewit-West K, Hunt SA, Applegate E. Today's Medical Assistant: Clinical and Administrative Procedures. Elsevier Health Sciences. 2012. https://books.google.com/books?id=YalYPI1KqTQC&pg=PA571
  5. Methatab Data Sheet. Medsafe. https://www.medsafe.govt.nz/profs/datasheet/m/Methatabs.pdf
  6. Metadon DnE (Oral lösning 1 mg/ml) • Bipacksedel | FASS Patient. fass.se. https://fass.se/product/20070329000030/pl

Data sources []

SourceStatusUpdated (UTC)
dosingok2026-11-20 12:47:11
drugsprook2026-11-20 12:47:07
erowidok2026-11-20 12:47:09
gsrsok2026-11-20 12:47:10
hmdbmissing (hmdb.ca refused automated access to HMDB0014477)2026-11-20 12:47:07
keggok2026-11-20 12:47:09
pubchemok2026-11-20 12:47:05
redditmissing (no r/tripreports posts mention it)2026-11-20 12:47:07
siderok2026-11-20 12:47:07
structureok2026-11-20 12:47:07
wikipediaok2026-11-20 12:47:07